Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2006;581:585–591. doi: 10.1007/978-0-387-33012-9_106

Structure and Dynamics of Sars Coronavirus Main Proteinase (MPRO)

Rolf Hilgenfeld 3, Kanchan Anand 4, Jeroen R Mesters 5, Zihe Rao 6, Xu Shen 7, Hualiang Jiang 8, Jinzhi Tan 9, Koen H G Verschueren 10
Editors: Stanley Perlman1, Kathryn V Holmes2
PMCID: PMC7123470  PMID: 17037602

The content is available as a PDF (906.1 KB).

Contributor Information

Stanley Perlman, Email: Stanley-Perlman@uiowa.edu

Kathryn V. Holmes, Email: Kathryn.Holmes@ucHSC.edu

References

  • 1.Groneberg DA, Hilgenfeld R, Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS) Respir. Res. 2005;6:8–23. doi: 10.1186/1465-9921-6-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Thiel V, Ivanov KA, Putics A, et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 2003;84:2305–2315. doi: 10.1099/vir.0.19424-0. [DOI] [PubMed] [Google Scholar]
  • 3.Gorbalenya AE, Koonin EV, Donchenko AP, Blinov VM. Coronavirus genome: prediction of putative functional domains in the non-structural polyprotein by comparative amino acid analysis. Nucl. Acids Res. 1989;17:4847–4861. doi: 10.1093/nar/17.12.4847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658. [DOI] [PubMed] [Google Scholar]
  • 5.Xiong B, Gui CS, Xu XY, et al. A 3D model of SARS-CoV 3CL proteinase and its inhibitors design by virtual screening, Acta Pharmacol. Sin. 2003;24:497–504. [PubMed] [Google Scholar]
  • 6.Anand K, Yang H, Bartlam M, Rao Z, Hilgenfeld R. In: Coronaviruses with Special Emphasis on First Insights Concerning SARS. Schmidt A, Wolff MH, Weber O, editors. Basel: Birkhäuser; 2005. pp. 173–199. [Google Scholar]
  • 7.Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteinases. PLoS Biology. 2005;e324:3. doi: 10.1371/journal.pbio.0030324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Anand K, Palm GJ, Mesters JR, et al. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J. 2002;21:3213–3224. doi: 10.1093/emboj/cdf327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yang H, Yang M, Ding Y, et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA. 2003;100:13190–13195. doi: 10.1073/pnas.1835675100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tan J, Verschueren KHG. K. Anand, et al. , pH-Dependent conformational flexibility of the SARS-CoV main proteinase (Mpro ) dimer: Molecular dynamics simulations and multiple X-ray structure analyses. J. Mol. Biol. 2005;354:25–40. doi: 10.1016/j.jmb.2005.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hsu M-F, Kuo C-J, Chang K-T, et al. Mechanism of the maturation process of SARS-CoV 3CL protease. J. Biol. Chem. 2005;280:31257–31266. doi: 10.1074/jbc.M502577200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chou C-Y, Chang H-C, Hsu W-C, et al. Quarternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004;43:14958–14970. doi: 10.1021/bi0490237. [DOI] [PubMed] [Google Scholar]
  • 13.Shi J, Wei Z, Song J. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: Defining the extra domain as a new target for design of highly specific protease inhibitors. J. Biol. Chem. . 2004;279:24765–24773. doi: 10.1074/jbc.M311744200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fan K, Wei P, Feng Q, et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. . 2004;279:1637–1642. doi: 10.1074/jbc.M310875200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hegyi A, Friebe A, Gorbalenya AE, Ziebuhr J. Mutational analysis of the active centre of coronavirus 3C-like proteases. J. Gen. Virol. . 2002;83:581–593. doi: 10.1099/0022-1317-83-3-581. [DOI] [PubMed] [Google Scholar]
  • 16.Ziebuhr J, Snijder EJ, Gorbalenya AE. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. . 2000;81:853–879. doi: 10.1099/0022-1317-81-4-853. [DOI] [PubMed] [Google Scholar]
  • 17.Yang J, Yu M, Jan YN, Jan LY. Stabilization of ion selectivity filter by pore loop ion pairs in an inwardly rectifying potassium channel. Proc. Natl. Acad. Sci. USA. 1997;94:1568–1572. doi: 10.1073/pnas.94.4.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chen S, Chen L, Tan J, et al. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization: Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J. Biol. Chem. 2005;280:164–173. doi: 10.1074/jbc.M408211200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hsu W-C, Chang H-C, Chou C-Y, Tsai P-J, Lin P-I, Chang G-G. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J. Biol. Chem. 2005;280:22741–22748. doi: 10.1074/jbc.M502556200. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Nidoviruses are provided here courtesy of Nature Publishing Group

RESOURCES